Reboa Giuliano, Gipponi Marco, Rattaro Andrea, Ciotta Giovanni, Tarantello Marco, Caviglia Angelo, Pagliazzo Antonio, Masoni Luigi, Caldarelli Giuseppe, Gaj Fabio, Masci Bruno, Verdi Andrea
Coloproctology Unit, Casa di Cura San Camillo, Forte dei Marmi, Lucca, Italy.
General Surgery and Breast Unit, IRCCS "San Martino-IST", L.go R. Benzi 10, 16132 Genoa, Italy.
Surg Res Pract. 2014;2014:710128. doi: 10.1155/2014/710128. Epub 2014 Jun 15.
CPH34 HV, a high volume stapler, was tested in order to assess its safety and efficacy in reducing residual/recurrent haemorrhoids. The clinical charts of 430 patients with third- to fourth-degree haemorrhoids undergoing SH in 2012-2013 were consecutively reviewed, excluding those with obstructed defecation (rectocele >2 cm; Wexner's score >15). Follow-up was scheduled at six and 12 months. Rectal prolapse exceeding more than half of CAD was reported in 341 patients (79.3%); one technical failure was reported (0.2%) without any serious untoward effect; and 1.3 stitch/patient (SD, 1.7) was required to achieve complete haemostasis. Doughnuts volume was higher (13.8 mL; SD, 1.5) in patients with a large rectal prolapse than with smaller one (8.9 mL; SD, 0.7) (P value <0.05). Residual and recurrent haemorrhoids occurred in 8 of 430 patients (1.8%) and 5 of 254 patients (1.9%), respectively. A high index of patient satisfaction (visual analogue scale = 8.9; SD, 0.9) coupled with a persistent reduction of constipation scores (CSS = 5.0, SD, 2.2) was observed. The wider prolapse resection well correlated with a clear-cut reduction of haemorrhoidal relapse, a high index of patient satisfaction, and clinically relevant reduction of constipations scores coupled with satisfactory haemostatic properties of CPH34 HV.
为评估大容量吻合器CPH34 HV在减少残余/复发性痔方面的安全性和有效性,对其进行了测试。连续回顾了2012年至2013年接受SH治疗的430例三至四度痔患者的临床病历,排除排便障碍患者(直肠膨出>2 cm;韦克斯纳评分>15)。计划在6个月和12个月时进行随访。341例患者(79.3%)报告直肠脱垂超过CAD的一半;报告1例技术失败(0.2%),无任何严重不良影响;实现完全止血需要每位患者1.3针(标准差,1.7)。直肠脱垂大的患者的痔核体积更高(13.8 mL;标准差,1.5),而直肠脱垂小的患者的痔核体积为8.9 mL(标准差,0.7)(P值<0.05)。430例患者中有8例(1.8%)出现残余痔和复发性痔,254例患者中有5例(1.9%)出现残余痔和复发性痔。观察到患者满意度较高(视觉模拟评分=8.9;标准差,0.9),同时便秘评分持续降低(便秘评分系统=5.0,标准差,2.2)。更广泛的脱垂切除与痔复发的明显减少、患者满意度高以及便秘评分在临床上的显著降低以及CPH34 HV令人满意的止血特性密切相关。